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. There was no evidence for antinociception with any of the three groups in the hot plate test (Fig. 1B) (Fig. 2) . In the tail flick test the antinociceptive effect of isoproterenol (40 nmol, i.t.) in rats receiving AtT-20 implants was significantly higher than control groups at 3 and 10 minutes (Fig. 2) . At 3 minutes in the hot plate test, both the AtT-20 and control groups showed an antinociceptive effect; the effect in the control group was considered to be due to the stress of handling during the injection.
At 10 minutes in the hot plate test, partial antinociception was maintained in the AtT-20 cellimplanted group but not in the control group.
Nine days after AtT-20 cell implantation, tail flick and hot plate response latencies were determined before and 5 minutes after isoproterenol injection. Before isoproterenol, tail flick and hot plate response latencies showed no difference between AtT-20 cell-implanted and control groups. However, isoproterenol (12, 40 and 120 nmol i.t. coadministered with ZK 62711) troduced dose-related tail flick (Fig. 3A) and hot plate (Fig. 3B) antinociception in the AtT-20 cellimplanted group. The highest dose of isoproterenol (120 nmol) did not produce antinociception in the control group. The anticiceptive effect of isoproterenol in the AtT-20 cell-implanted group could be blocked by coadministration of the opioid antagonist naloxone (3tg, i.t.), a dose that had no effect on its own in any of the three groups.
Isoproterenol also produced antinoeieeption in rats receiving AtT-20/hENK cell implants, although these cells had lower apparent efficacy than AtT-20 cells. Figure 4 presents In the tail flick test, a two-factor, repeated measures ANOVA showed significant differences among the three groups (F2,63=5, p<0.01). The AtT-20/hENK cell-implanted group showed more antinociception than the AtT-20 cell-implanted and control groups. Significant post-hoe comparisons are indicated by *(p<0.05). In the hot plate test, a two-factor, repeated measures ANOVA showed no significant differences among the three groups (F2,63=1.8, p=0.12). Each point represents the mean +/-SEM (22 rats in each group). VOLUME 4, NO. 1, 1993 Tail flick Immunohistochemistry showed the presence of enkephalin-positive cells surrounding the spinal cords of AtT-20/hENK cell-implanted rats. Cells, which were not present in control animals, surrounded the spinal cords of AtT-20 cellimplanted rats, but these were enkephalin-negative. This result was as expected, because only the genetically modified AtT-20/hENK cell line secretes enkephalin/8/.
This study has identified and characterized pharmacologically an antinociceptive effect of opioid-producing AtT-20 and genetically modified AtT-20/hENK cells implanted around rat spinal cord. Implantation of cell lines may provide a method to control chronic pain in patients. The present study is an initial step in the development of cell lines for transplantation in pain syndromes. In future studies, it will be important to determine whether the implanted cells release opioid peptides for long periods post implantation, and whether encapsulation of the implanted cells would reduce the metastatic potential of the cells without compromising their antinocieeptive effect.
